Your browser doesn't support javascript.
loading
Myeloid-derived suppressor cells modulate B-cell responses.
Lelis, Felipe J N; Jaufmann, Jennifer; Singh, Anurag; Fromm, Katja; Teschner, Annkathrin Chiara; Pöschel, Simone; Schäfer, Iris; Beer-Hammer, Sandra; Rieber, Nikolaus; Hartl, Dominik.
Affiliation
  • Lelis FJN; Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tuebingen, Tuebingen, Germany; Department of Pediatrics, Department of Infectious Diseades, Boston Children's Hospital, Harvard Medical School,300 Longwood Avenue, Boston, MA 02115, USA.
  • Jaufmann J; Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology and ICePhA, University of Tuebingen, 72074, Tuebingen, Germany.
  • Singh A; Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tuebingen, Tuebingen, Germany.
  • Fromm K; Biozentrum, University of Basel, Infection Biology, Klingelberstrasse 50/70, 4056 Basel, Switzerland.
  • Teschner AC; Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tuebingen, Tuebingen, Germany.
  • Pöschel S; University Women's Hospital, Core Facility Imagestream, University of Tuebingen, Tuebingen, Germany.
  • Schäfer I; Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tuebingen, Tuebingen, Germany.
  • Beer-Hammer S; Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology and ICePhA, University of Tuebingen, 72074, Tuebingen, Germany.
  • Rieber N; Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tuebingen, Tuebingen, Germany; Department of Pediatrics, Kinderklinik München Schwabing, Klinikum Schwabing, StKM GmbH und Klinikum rechts der Isar, Technische Universität München, 80804 Munich, Germany.
  • Hartl D; Children's Hospital and Interdisciplinary Center for Infectious Diseases, University of Tuebingen, Tuebingen, Germany; Roche Pharma Research & Early Development (pRED), Immunology, Inflammation and Infectious Diseases (I3) Discovery and Translational Area, Switzerland. Electronic address: domini
Immunol Lett ; 188: 108-115, 2017 08.
Article in En | MEDLINE | ID: mdl-28687234
Myeloid-derived suppressor cells (MDSCs) are key regulators of adaptive immunity by suppressing T-cell functions. However, their potential action on or interaction with B cells remained poorly understood. Here we demonstrate that human polymorphonuclear MDSCs differentially modulate B-cell function by suppressing B-cell proliferation and antibody production. We further demonstrate that this MDSC-mediated effect is cell contact dependent and involves established mediators such as arginase-1, nitric oxide (NO), reactive oxygen species (ROS) as well as B-cell death. Collectively, our studies provide novel evidence that human MDSCs modulate B cells, which could have future implications for immunotherapy approaches.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Cell Communication / Immunomodulation / Myeloid-Derived Suppressor Cells Limits: Humans Language: En Journal: Immunol Lett Year: 2017 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B-Lymphocytes / Cell Communication / Immunomodulation / Myeloid-Derived Suppressor Cells Limits: Humans Language: En Journal: Immunol Lett Year: 2017 Document type: Article Affiliation country: Country of publication: